
Strategic and science-driven Clinical Operations Leader with 10+ years of experience managing global clinical trials (Phase I–IV, ISR) across Oncology, Dermatology, Immunology, and Biosimilars. Proven track record of leading 7 Global and Local Phase I, III and IV studies, 40+ ISR global studies and delivering trials on time (>95% adherence), within budget (~$5M–$20M programs), and with high-quality data. Expertise in cross-functional leadership, vendor oversight, and risk-based execution, with demonstrated ability to improve timelines, optimize costs, and ensure regulatory compliance
High-level analysis of gene expression microarrays and SNP microarrays
Mcode (Molecular complex detection) detecting highly interconnected regions in large protein- protein interaction networks that represent molecular complex
Cytoscape to perform Network analysis of expressed genes in gene-gene interaction